Who Paid My Doc
Dexcom G7 GSS (161)
MedicalSupply Endocrinology
PDI 00386270004109
General payments
$5,247,259
Research payments
$4,321,398
Through program year 2025, $5,247,259 in general payments and $4,321,398 in research payments were reported against Dexcom G7 GSS (161) (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,675,392 | 3,552 |
| 2025 | Research | $1,236,889 | 202 |
| 2024 | General | $1,249,912 | 2,114 |
| 2024 | Research | $996,003 | 98 |
| 2023 | General | $2,321,955 | 4,449 |
| 2023 | Research | $2,088,507 | 122 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,115 general · 422 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.